Health and Fitness Health and Fitness
Wed, April 24, 2013
[ Wed, Apr 24th 2013 ] - Market Wire
Acquisition of PROLOR Biotech, Inc. by OPKO Healt .. t Be in the Best Interests of PROLOR Shareholders
[ Wed, Apr 24th 2013 ] - Market Wire
Brookdale Announces First Quarter 2013 Release and Earnings Call
[ Wed, Apr 24th 2013 ] - Market Wire
Galapagos raises EUR54 million
[ Wed, Apr 24th 2013 ] - Market Wire
Thallion Announces 2013 First Quarter Operating Results
[ Wed, Apr 24th 2013 ] - Market Wire
BioScrip Closes Underwritten Offering Of Common Stock
[ Wed, Apr 24th 2013 ] - Market Wire
Life Care Medical Devices Ltd Announces CE Mark A .. ialization For Laparoscopic Surgery Access Device
[ Wed, Apr 24th 2013 ] - Market Wire
Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference
[ Wed, Apr 24th 2013 ] - Market Wire
Pharmacyclics Announces Date of Financial Results .. e Months Ended March 31, 2013 and Conference Call
[ Wed, Apr 24th 2013 ] - Market Wire
Pomerantz Law Firm Investigates Claims on Behalf of Investors of PROLOR Biotech, Inc. - PBTH
[ Wed, Apr 24th 2013 ] - Market Wire
Micro Imaging Technology to Exhibit the MIT 1000 at the 2013 Food Safety Summit
[ Wed, Apr 24th 2013 ] - Market Wire
Recent Study Concludes Quantitative Cytology Effe .. for Identifying High-Risk Epithelial Oral Lesions
[ Wed, Apr 24th 2013 ] - Market Wire
Biologix Hair Inc. Appoints Dr. Arthur G. Handal to Medical Advisory Board
[ Wed, Apr 24th 2013 ] - Market Wire
Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
[ Wed, Apr 24th 2013 ] - Market Wire
3SBio Inc. Enters Into Amendment to Merger Agreem .. ot;;Going Privatequot;; Transaction
[ Wed, Apr 24th 2013 ] - Market Wire
Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity
[ Wed, Apr 24th 2013 ] - Market Wire
Gentiva Health Services Schedules First Quarter 2 .. rnings Call And Webcast For Thursday, May 9, 2013
[ Wed, Apr 24th 2013 ] - Market Wire
NuVasive(R) Announces New Office Opening in Japan
[ Wed, Apr 24th 2013 ] - Market Wire
Paladin Labs Announces the Canadian Launch of AmnioSense(TM)
[ Wed, Apr 24th 2013 ] - Market Wire
Trimel Pharmaceuticals Corporation Completes $40 Million Equity Financing
[ Wed, Apr 24th 2013 ] - Market Wire
Top-line Data Show AcelRx Pharmaceuticals' ARX-04 .. y Endpoint in Dose-Finding Phase 2 Clinical Trial
[ Wed, Apr 24th 2013 ] - Market Wire
STATS ChipPAC Appoints James A. Norling as Chairman
[ Wed, Apr 24th 2013 ] - Market Wire
Bullish $10 Million Bet Placed by CRO After CEL-SCI Acts to Accelerate Phase III Enrollment
[ Wed, Apr 24th 2013 ] - Market Wire
Omeros to Present at the 12th Annual Needham Healthcare Conference
Tue, April 23, 2013
[ Tue, Apr 23rd 2013 ] - Market Wire
OPKO Health To Acquire PROLOR Biotech
[ Tue, Apr 23rd 2013 ] - Market Wire
BD anuncia el permiso FDA 510(k) y lanzamiento co .. UltraSafe PLUSa" con proteccin pasiva para aguja
[ Tue, Apr 23rd 2013 ] - Market Wire
BD reoit le feu vert de la FDA et annonce le lanc .. otection passive de l'aiguille BD UltraSafe PLUSa
[ Tue, Apr 23rd 2013 ] - Market Wire
Thallion Delays Annual Meeting Date
[ Tue, Apr 23rd 2013 ] - Market Wire
Arrhythmia Research Technology, Inc. Receives NYSE MKT Exchange Compliance Notice
[ Tue, Apr 23rd 2013 ] - Market Wire
Levi &;; Korsinsky Notifies Investors W .. t in Star Scientific, Inc. of Class Action Lawsui
[ Tue, Apr 23rd 2013 ] - Market Wire
Aeterna Zentaris Newly Appointed CEO, David A. Do .. yst and Investor Conference Call on Thursday, Apr

Aeterna Zentaris Newly Appointed CEO, David A. Dodd, to Host Introductory Analyst and Investor Conference Call on Thursday, Apr


Published on 2013-04-23 13:30:47 - Market Wire
  Print publication without navigation


Aeterna Zentaris Newly Appointed CEO, David A. Dodd, to Host Introductory Analyst and Investor Conference Call on Thursday, April 25, 2013

QUEBEC CITY, April 23, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: [ AEZS ]) (TSX: AEZ) (the "Company") newly appointed President and CEO, David A. Dodd will hold an introductory analyst and investor conference call on Thursday, April 25, 2013 at 4:30 p.m., Eastern Time.

Participants may access the live webcast via the Company's website at [ www.aezsinc.com ] in the "Newsroom" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. The Company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. For more information please visit [ www.aezsinc.com ].

SOURCE AETERNA ZENTARIS INC.



Contributing Sources